Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akhil P. Santhosh
Observed names:
AKHIL Santhosh,
Akhil P Santhosh,
Akhil Santhosh
Institution:
All India Institute of Medical Sciences
Observed institutions:
DR. B.R.A. Institute Rotary Cancer Hospital,
Post Graduate Institute of Medical Education and Research,
All India Institute of Medical Sciences
ORCID:
0000-0001-6780-0406
Observed ORCID:
0000-0001-6780-0406
OpenAlex ID:
A5061577917
Works
21
Awards
1
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
2024
·
Akhil Santhosh
, Atul Sharma
, et al.
·
Journal of Clinical Oncology
·
57
Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study)
2022
·
Akhil Santhosh
, Akash Kumar
, et al.
·
Trials
·
24
PDF
Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis
2020
·
Akhil P. Santhosh
, Manoj Kumar Goyal
, et al.
·
Acta Neurologica Scandinavica
·
21
PDF
Randomized double-blind, placebo-controlled study of topical diclofenac in prevention of hand-foot syndrome in patients receiving capecitabine.
2023
·
AKHIL Santhosh
, Atul Batra
, et al.
·
Journal of Clinical Oncology
·
3
Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH study
2025
·
Ghazal Tansir
, Akhil Santhosh
, et al.
·
ecancermedicalscience
·
2
PDF
Real world treatment patterns and outcomes in metastatic EGFR mutation–positive NSCLC patients: A retrospective study from a tertiary care cancer center in India.
2025
·
Jyothis P. Jose
, Akhil Santhosh
·
Journal of Clinical Oncology
·
2
PDF
Assessment of long-term toxicities of imatinib in CML: Experience from a tertiary care cancer centre in south India.
2025
·
Akhil Santhosh
, Prasanth V. Parameswaran
, et al.
·
Journal of Clinical Oncology
·
2
Topical diclofenac in prevention of capecitabine associated HFS in patients with breast cancer: An exploratory subgroup analysis of the D-ToRCH study.
2023
·
Akhil Santhosh
, Atul Sharma
, et al.
·
JCO Global Oncology
·
2
Quality of life assessment in testicular non-seminomatous germ cell tumour survivors
2023
·
Neha Pathak
, Abhishek Raj
, et al.
·
Journal of Cancer Survivorship
·
2
PDF
Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps
2026
·
Enes Erul
, Sergio Cifuentes-Canaval
, et al.
·
Drug Design Development and Therapy
·
1
PDF
Where Science Pauses, and the Soul Begins: Pastries, Prognosis, and the Poetry of Passing
2026
·
Nihanthy D. Sreenath
, Akhil Santhosh
·
Indian Journal of Medical and Paediatric Oncology
PDF
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study
2026
·
Hemavathi Baskarane
, Mohit Kumar Divakar
, et al.
·
Frontiers in Pharmacology
PDF
Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW
2025
·
Akhil Santhosh
, Nihanthy D Sreenath
·
The Lancet
Succinate dehydrogenase deficient GIST: Case series and review of literature from a tertiary care center in India
2025
·
Akhil P Santhosh
, Sameer Rastogi
, et al.
·
Indian Journal of Cancer
Final Overall Survival Results of PRIMA: The Niraparib Conundrum
2025
·
Akhil Santhosh
·
Indian Journal of Medical and Paediatric Oncology
PDF
Trastuzumab Duocarmazine in Pretreated Her2-Positive Breast Cancer: Has the “TULIP” Bloomed a Bit Too Late?
2025
·
Akhil Santhosh
·
Indian Journal of Medical and Paediatric Oncology
PDF
Pretransplantation optimisation for unresectable colorectal liver metastases: the TransMet trial
2025
·
Akhil Santhosh
, Annie Baa
, et al.
·
The Lancet
Rezvilutamide in metastatic, hormone-sensitive prostate cancer
2023
·
Akhil P. Santhosh
, Ajay Gogia
·
Cancer Research Statistics and Treatment
Is there an optimal regimen for double hit lymphomas?
2022
·
Akhil Santhosh
, Ajay Gogia
·
Cancer Research Statistics and Treatment
Is fulvestrant the correct choice for early switch with rising ESR1 mutation?
2022
·
Akhil P. Santhosh
, Ajay Gogia
·
Cancer Research Statistics and Treatment
Is the Hans algorithm outdated?
2022
·
Akhil Santhosh
, Ajay Gogia
·
Cancer Research Statistics and Treatment
Show more works
View as search
Works count:
21
Citation count:
116
H-index:
3
I10-index:
3
Year
Topic
Type